Suchergebnisse - (Subject:"Lopinavir")

PubPharm (790)

71

Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV/AIDS

enthalten in: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | 2020

von Azevedo, L. | Ximenes, R. | Monteiro, P. | +2

72

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa

enthalten in: PloS one | 2020

von Tchounga, B. | Charpentier, C. | Coffie, P. | +4

73

Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination : a comparative analysis

enthalten in: AIDS (London, England) | 2019

von Venkatesh, K. | Farhad, M. | Fenton, T. | +7

74

Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices

enthalten in: Antimicrobial agents and chemotherapy | 2019

von Martinec, O. | Huliciak, M. | Staud, F. | +3

75

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288) : a prospective strategy study

enthalten in: The lancet. HIV | 2019

von Grinsztejn, B. | Hughes, M. | Ritz, J. | +80

76

Pharmacokinetics of adjusted-dose 8-hourly lopinavir/ritonavir in HIV-infected children co-treated with rifampicin

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Rabie, H. | Rawizza, H. | Zuidewind, P. | +5

77

Symptomatic HIV CNS viral escape among patients on effective cART

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2019

von Manesh, A. | Barnabas, R. | Mani, S. | +5

78

Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052) : a randomised, open-label, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2019

von Venter, W. | Moorhouse, M. | Sokhela, S. | +15

CommentIn: Lancet HIV. 2019 Jul;6(7):e412-e413. - PMID 31202689

79

A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia

enthalten in: Drug safety | 2019

von Adenuga, B. | Rennie, T.

80

Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug

enthalten in: Journal of drug targeting | 2019

von Nassar, T. | Rohald, A. | Naraykin, N. | +5